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Abstract: 
Measurement of body composition is proving 
increasingly important in clinical nutrition and research. 
In current study we investigated about the effect of body 
composition on cisatracurium efficiency. In this 
descriptive cross sectional study, 180 patients with 
elective non-cardiac surgery under general anesthesia 
with muscle relaxation and under ventilation with 
ventilator referred to Shahid Modarres Hospital were 
selected randomly from simple random sampling. Fat 
mass and muscle mass(BMI and TBW ) in patients, that 
measured by BODY COMPOSION ANALYZER set, 
was recorded and compared with duration of effect time 
of cisatracurium, extubation time, cisatracurium dose 
during oeration , recovery time, and onset time 
Correlation between quantitative variables was 
determined using Pearson correlation coefficient and 
Spearman rank tests for statistical analysis of data using 
SPSS 21 software. In this study p value<0.05 considered 
statistically significant. it was concluded that duration of 
effect time of cisatracurium, extubation time, recovery 
time, and onset time were decreased with increased 
muscle mass but the cisatracurium dose during operation 
was increased, in contrast duration of effect time of 
cisatracurium, extubation time, recovery time, and onset 
time were increased with increased fat mass but the 
cisatracurium dose during operation was decreased. 
 
Introduction 
Body composition is the proportion of fat and fat-free 
mass in your body. A healthy body composition is one 
that includes a lower percentage of body fat and a higher 
percentage of fat-free mass, which includes muscle, 
bones, and organs.(1) Measurement of body composition 
is proving increasingly important in clinical nutrition and 
research. Skinfold thickness is a simple means of 
estimating body composition which is widely used in 
children, but there is little information on its validity.(2) 
 Body composition and growth are key components of 
health in both individuals and populations(3). 
Measurement of skinfold thickness is currently widely 
used n children for clinical, research and epidemiological 
purposes but there are doubt about  validity in 
efficiency.(4) Body mass index is commonly used as a 
surrogate measure for body fat content .(5) 
Accurate in vivo measurement of FFM may be even 
more difficult than that of TBW. Although FFM can be 
estimated by total body Mass, anthropometry, and 
bioimpedance methods, their value in investigating FFM 
hydration is obviously limited because of their low 
accuracy. Streat et al , for example, estimated FFM by 
skinfold thickness anthropometry.(6) 
Previous studies have used only weight, creatinine 
excretion, or derived anthropometric measures to 
estimate muscle mass.(7) fat mass increase with age 
(with a redistribution of body fat), whereas muscle mass 
decreases.* anesthesia controlled time and turn over time 
is two of the most important factors that regulate 
operation room efficiency. Extubation time is of special 
interests to surgeons and anesthesiologists because it 
could be affected by different anesthetic agents or 
techniques. Prolonged extubation is an important factor 
that would decrease operation room efficiency. 
Prolonged extubation time would cause slowing of work 
flow, having OR members staying idly waiting for 
extubation, and the surgeon have to wait longer for next 
operation.surgeon always want patients quick to awaken. 
Accordingly choosing appropriate anesthetic agents or 
techniques to avoid prolonged extubation is essential for 
anesthesiologists in order to improve the efficiency of 
OR.(8) 
cisatracurium has been used widely in managing 
intensive care unit patients, as well as in general 
anesthesia.(9) Clinical use of these drugs would be 
facilitated by determining effective combination doses 
and the pharmacodynamic characteristics that determine 
the extent of synergistic effects.(10) Because corrected 
body weight(CBW)  was used as the cisatracurium 
(CisA) dosage calculation, so muscular mass of the obese 
patients may have been a great importance.(11) Li JY et 
al. (2016) compare the pharmacokinetics of cisatracurium 
between normal weight patients and morbidly obese 
patients and undertook that Cisatracurium doses 
according to fat-free mass is clinically reasonable for 




timing of tracheal intubation should be delayed.(12) 
Salihoglu et al. studied about the neuromuscular effects 
of cisatracurium in morbidly obese as compared to 
control group of normal body weight patients and they 
conclude that neuromuscular agents must be monitored in 
the morbidly obese patients.(13) 
In current study we investigated about the effect of body 
composition on cisatracurium efficiency.  
 
Material and method 
In this descriptive cross sectional study, 180 patients with 
elective non-cardiac surgery under general anesthesia 
with muscle relaxation and under ventilation with 
ventilator referred to Shahid Modarres Hospital in 2018 
and 2019 were selected randomly from simple random 
sampling. The exclusion criteria were the history of 
neuromuscular disease and use of drugs interfering with 
neuromuscular transmission, allergy to neuromuscular 
blocking agents, known intubation problem. 
Identification of relevant trials was performed by study 
the papers dated from 1995 to 2018.        
Fat mass and muscle mass(BMI and TBW ) in patients, 
that measured by BODY COMPOSION ANALYZER 
set, was recorded. Before the anesthetic induction, a 
catheter 18 was inserted for administration of fluids and 
drugs. initially the patients were Preoxygenated with 
100% oxygen and then premedication, midazolam 0.02 
mg / kg and 2 micrograms / kg Fentanyl were used. 2.5 
mg / kg propofol For anesthesia induction and 0.2 mg / 
kg cis-atracurium to access muscle relaxant were injected 
slowly. Cisatracurium is made by ROSAMED company, 
The optimum dose of the muscle relaxant was based on 
the TBW. In order to maintain anesthesia, sevoflurane 
was used with MAC 3 at 50% oxygen and air. 
cisatracurium supplement was used if necessary during 
the operation, and finally the total dose of muscle 
relaxant was recorded in the questionnaire and the onset 
time cisatracurium induction, based on TOF reached to 
zero, was recorded. During operation, the monitoring was 
involved electrocardiography, non-invasive blood 
pressure, pulse oximetry, capnography, temperature, TOF 
and recovery (DBS) and also BIS monitoring throughout 
the duration of the operation to maintain anesthesia depth 
. Upon completion of the operation and stopping the 
anesthetic gas, it took time for the patient to spontaneous 
breathing, and the Duration time for extubation (on the 
arrival of TOF to 3) and the Duration Time In Recovery 
Ward (based on the Aldrete's original scoring system 
recovery criteria) were recorded in the questionnaire.  fat 
and muscle mass , the onset time, the drug effect and 
duration of the drug effect were measured and Decisions 
about the appropriate dosage of muscle relaxant to reduce 
the occurrence of side effects due to the effect of residual 
muscle relaxant such as respiratory depression and 
hypoxia and stay Muscle relaxation is in recovery were 
taken. The body composition effect on onset time of 
cisatracurium, duration time of cisatracurium, extubation 
time, recovery time, Total dose of the cisatracurium 
consumed in the whole operation were collected and they 
were recorded in a pre-made checklist. The results 
obtained for quantitative variables Worth mean and 
standard deviation (mean ± SD) and qualitative variables 
were expressed as the percentage of the class. Correlation 
between quantitative variables was determined using 
Pearson correlation coefficient and Spearman rank tests 
for statistical analysis of data using SPSS 21 software. In 
this study p value<0.05 considered statistically 
significant. All measurements are expressed as mean 
±SD or 95% confidence interval. 
 
Table 1. demographic information 




age 36.19±11.9 18 60 
Male/female 98/82 - - 
TBW 77.33±15.1 50 111 
BMI 23.97±3.8 18 36 
 
Table2. 






4.27±1.13 2 8 
Fat mass 30.14±7.5 14 45 
Muscle mass 33.22±4.01 24 42 
Recovery time 44.63±9.14 25 65 
Cisatrocurium 
dose induction 
14.85±3.21 10 22 












Age.fat mass 0.001 0.236 
Age.muscle mass 0.000 -0.273 
Gender.fat mass 0.000 0.674 
Gender.muscle mass 0.0000 -0.650 
TBW.fat mass 0.011 -0.189 
TBW.muscle mass 0.000 0.351 
BMI.fat mass 0.004 0.422 
BMI.muscle mass 0.000 -0.112 
 
Results 
among 180 patients in this study, there was 98 males and 
82 females and the average age of the patients were 
36.19±11.58. The average of TBW and BMI were 
77.33±15.14 and 23.97±3.84 respectively (table 1) 
the  effect of fat mass and muscle mass on extubation 
time (4.27±1.31), recovery time (44.63±9.14), 
cisatracurium dose induction (14.85±3.21), onset time 
(4.26±1.14) and duration time (45.19±9.31) were 
measured and there were significant difference between 
all of these variables with fat and muscle mass(table 2). 
Extubation time and duration time and recovery time and 
onset time were increased in a patients with lower range 
of  muscle mass but the cisatracurium dose were 
decreased in these patients.  
In addition according to statistical analysis, there were 
significant difference between age, gender, TBW and 
BMI with both fat mass and muscle mass. According to 
Pearson correlation coefficient fat mass were increased in 
older patients, and male′s muscle mass was more than 
females and patients with higher BMI had more fat mass 
than the patients with low BMI. also the range of fat 
mass were increased with decreasing of TBW (table 3).  
Discussion 
The proper use of neuromuscular agents during the 
operation is necessary for surgical condition. However, 
because of incomplete recovery of muscle relaxation 
risks, the appropriate dosage of anesthetics are very 
important. 
On the other hand, administration of high saline doses 
prolongs muscle relaxation and, as a result, the process of 
extubation and longer recovery of the patient and 
increased recovery time, including the loss of suction 
 
 
Figure 1. relationship between  muscle mass and 
extubation time, recovery time, cisatracurium induction, 
onset time, duration time. 
Cisatracurium is a bundle of benzylisoquinolones with a 
long-lasting effect of 30-40 minutes after one dose. The 
dose of induction is 0.15 mg / kg for cisatracurium. Both 
cisatracurium and atracurium are removed from the body 
























Figure 2. relationship between  fat  mass and extubation 
time, recovery time, cisatracurium induction, onset time, 
duration time. 
In this study, we calculated the maximum effect time of 
muscle relaxant by calculating the percentage of muscle 
mass, and thus prevent side effects including hypoxia and 
other complications.  
Aging and gender are commonly effect on the body 
composition. We reported that older patient and males 
have more muscle mass than the younger patients and 
females.kim et al.   also achieved the same result.(9) 
Janssen et al. investigated in multiethnic sample of 468 
men and women who ranged in age from 18 to 88 yr. and 
result in Men had significantly (P < 0.001) more SM in 






Duration time*muscle mass 0.000 -0.687 
Duration time * fat mass 0.000 0.774 
extubation time*muscle mass 0.000 -0.700 
extubation time * fat mass 0.000 0.788 
recovery time*muscle mass 0.000 -0.714 
recovery time * fat mass 0.000 0.799 
Cisatracurium dose *muscle 
mass 
0.000 0.363 
Cisatracurium dose * fat 
mass 
0.000 -0.348 
onset time*muscle mass 0.000 -0.704 
onset time * fat mass 0.000 0.818 
 
As it is shown in table 4, there are significant difference 
between muscle mass and duration of effect time of 
cisatracurium, extubation time, recovery time, 
cisatracurium dose during operation and onset time. The 
differences between this variables and fat mass were also 
significant. 
Chan et al studied on anesthesia-controlled time and 
factors that contribute to prolonged extubation in open 
colorectal surgery and concluded that the anesthesia-
controlled time was similar in desflurane anesthesia and 
propofol-based total intravenous anesthesia for open 
colorectal surgery in that hospital. Surgical time greater 
than 210 minutes, as well as age, contributed to 
prolonged extubation.(15)  
Jung et al. had attemped to determine whether or not a 
priming technique with rocuronium or cisatracurium can 
affect clinical duration or recovery profiles of 
cisatracurium. They concluded that Priming with 
rocuronium for 3 minutes resulted in significantly 
accelerated onset of cisatracurium. However, it did not 
affect the clinical duration and recovery profiles of 
cisatracurium.(16) 
Breslin et al. has conducted research on 
pharmacodynamics interactions between cisatracurium 
and rocuronium. They administered rocuronium 0.6 
mg/kg followed by cisatracurium 0.03 mg/kg when the 
first twitch in the TOF had recovered to 25%, and found 
that clinical duration of maintenance doses of 
cisatracurium was prolonged by 33%.(17) 
A  large number of studies have been conducted for 
establishment of pro per methods for reduction of onset 
time of action with cisatracurium.(18-20) 
ZIYA SALİHOĜLU et al. studied On 40 patients with 
ocular obesity, it was concluded that the effects of 
cisatracurium in the obese person were different with 
those in the control group. In fact, changes in the 
pharmacological dynamics of muscle relaxant bread were 
due to polarization and hydrofoil and distribution of these 
drugs in the massif and Lean tissues are affected by 
obesity. In fact, the total body weight of water in the 
normal person is 65%, and in contrast to the obese 
person, it will reach 40%, which has a large impact on 





















study we concluded that the dose of cisatracurium was 
decreased in patients with higher fat mass.(12) the same 
as current study, Kirkegaard-Nielsen et al declared that in 
people with increased fat mass, dosage regimens should 
be reduced based on body weight.(21) 
Conclusion. In this study, it was concluded that duration 
of effect time of cisatracurium, extubation time, recovery 
time, and onset time were decreased with increased 
muscle mass but the cisatracurium dose during operation 
was increased, in contrast duration of effect time of 
cisatracurium, extubation time, recovery time, and onset 
time were increased with increased fat mass but the 
cisatracurium dose during oeration was decreased. 
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